Literature DB >> 26118945

Targeted neural differentiation of murine mesenchymal stem cells by a protocol simulating the inflammatory site of neural injury.

Milada Chudickova1,2, Petr Bruza3, Alena Zajicova1, Peter Trosan1,2, Lucie Svobodova1, Eliska Javorkova1,2, Sarka Kubinova1, Vladimir Holan1,2.   

Abstract

Damaged neural tissue is regenerated by neural stem cells (NSCs), which represent a rare and difficult-to-culture cell population. Therefore, alternative sources of stem cells are being tested to replace a shortage of NSCs. Here we show that mouse adipose tissue-derived mesenchymal stem cells (MSCs) can be effectively differentiated into cells expressing neuronal cell markers. The differentiation protocol, simulating the inflammatory site of neural injury, involved brain tissue extract, fibroblast growth factor, epidermal growth factor, supernatant from activated splenocytes and electrical stimulation under physiological conditions. MSCs differentiated using this protocol displayed neuronal cell morphology and expressed genes for neuronal cell markers, such as neurofilament light (Nf-L), medium (Nf-M) and heavy (Nf-H) polypeptides, synaptophysin (SYP), neural cell adhesion molecule (NCAM), glutamic acid decarboxylase (GAD), neuron-specific nuclear protein (NeuN), βIII-tubulin (Tubb3) and microtubule-associated protein 2 (Mtap2), which are absent (Nf-L, Nf-H, SYP, GAD, NeuN and Mtap2) or only slightly expressed (NCAM, Tubb3 and Nf-M) in undifferentiated cells. The differentiation was further enhanced when the cells were cultured on nanofibre scaffolds. The neural differentiation of MSCs, which was detected at the level of gene expression, was confirmed by positive immunostaining for Nf-L protein. The results thus show that the simulation of conditions in an injured neural tissue and inflammatory environment, supplemented with electrical stimulation under physiological conditions and cultivation of cells on a three-dimensional (3D) nanofibre scaffold, form an effective protocol for the differentiation of MSCs into cells with neuronal markers.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adipose-derived mesenchymal stem cells; electrical stimulation; mouse; nanofibre scaffold; neural differentiation; neural injury

Mesh:

Substances:

Year:  2015        PMID: 26118945     DOI: 10.1002/term.2059

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  5 in total

1.  Brain Extract of Subacute Traumatic Brain Injury Promotes the Neuronal Differentiation of Human Neural Stem Cells via Autophagy.

Authors:  Zhenghui He; Lijian Lang; Jiyuan Hui; Yuxiao Ma; Chun Yang; Weiji Weng; Jialin Huang; Xiongfei Zhao; Xiaoqi Zhang; Qian Liang; Jiyao Jiang; Junfeng Feng
Journal:  J Clin Med       Date:  2022-05-11       Impact factor: 4.964

2.  Therapeutic effects of human umbilical cord mesenchymal stem cells transplantation on hypoxic ischemic encephalopathy.

Authors:  Bingchuan Xie; Ping Gu; Wenting Wang; Ci Dong; Lina Zhang; Jun Zhang; Huimiao Liu; Fucheng Qiu; Rui Han; Zhenqing Zhang; Baoyong Yan
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

3.  Emergence of signs of neural cells after exposure of bone marrow-derived mesenchymal stem cells to fetal brain extract.

Authors:  Iman Razeghian Jahromi; Davood Mehrabani; Ali Mohammadi; Mohammad Mahdi Ghahramani Seno; Mehdi Dianatpour; Shahrokh Zare; Amin Tamadon
Journal:  Iran J Basic Med Sci       Date:  2017-03       Impact factor: 2.699

Review 4.  Extrapolating neurogenesis of mesenchymal stem/stromal cells on electroactive and electroconductive scaffolds to dental and oral-derived stem cells.

Authors:  Boon Chin Heng; Yunyang Bai; Xiaochan Li; Xuehui Zhang; Xuliang Deng
Journal:  Int J Oral Sci       Date:  2022-02-24       Impact factor: 24.897

5.  Perspectives of Stem Cell-Based Therapy for Age-Related Retinal Degenerative Diseases.

Authors:  Vladimir Holan; Barbora Hermankova; Jan Kossl
Journal:  Cell Transplant       Date:  2017-09       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.